인슐린 저항과 B세포 기능이 당뇨병이 없는 성인의 항상성 모델 평가에 의해 결정되는 것에 대한 상대적 요인
The Relative Factors to Insulin Resistance and b Cell Function Determined by Homeostasis Model Assessment in Nondiabetic Adults
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Insulin resistance and pancreatic beta cell dysfunction have been established as being related to the diabetes. Lately, what is emphasizing is that those have been shown as something related to the metabolic syndrome and cardiovascular disease. Homeostasis model assessment (HOMA), simple index is calculated on blood levels of fasting glucose and insulin. And HOMA has been widely validated and applied for insulin resistance and pancreatic beta cell dysfunction. We also assessed the factors relative to insulin resistance and β cell function determined by HOMA. The data from the 2010 Korean National Health and Nutrition Examination Survey were used. Analysis was done for 3,465 nondiabetic subjects (male 1,357, female 2,108). At baseline, anthropometric measurements were done and fasting glucose, insulin, lipid (Total cholesterol, HDL cholesterol, LDL cholesterol and Triglycerides) profiles were measured. HOMA-insulin resistance (HOMA-IR) and beta cell function (HOMA β-cell) were calculated from fasting glucose and insulin levels. In male, the value of HOMA-IR and HOMA β-cell was the highest among 30's and decreased as the age increased. In female, the value of HOMA-IR increased with age, while HOMA β-cell decreased. High HOMA-IR and low HOMA β-cell were associated with the highest value of fasting glucose and systolic blood pressure. Low HOMA-IR and high HOMA β-cell showed the lowest concentration of fasting glucose and the highest concentration of HDL cholesterol. High HOMA-IR and high HOMA β-cell were connected with BMI, Total cholesterol, LDL cholesterol, and Triglycerides. There was a negative correlation between HOMA β-cell and age. The correlation coefficients of HOMA-IR and HOMA β-cell showed the highest value among weight, BMI and WC.
Abstract
Insulin resistance and pancreatic beta cell dysfunction have been established as being related to the diabetes. Lately, what is emphasizing is that those have been shown as something related to the metabolic syndrome and cardiovascular disease. Homeostasis model assessment (HOMA), simple index is calculated on blood levels of fasting glucose and insulin. And HOMA has been widely validated and applied for insulin resistance and pancreatic beta cell dysfunction. We also assessed the factors relative to insulin resistance and β cell function determined by HOMA. The data from the 2010 Korean National Health and Nutrition Examination Survey were used. Analysis was done for 3,465 nondiabetic subjects (male 1,357, female 2,108). At baseline, anthropometric measurements were done and fasting glucose, insulin, lipid (Total cholesterol, HDL cholesterol, LDL cholesterol and Triglycerides) profiles were measured. HOMA-insulin resistance (HOMA-IR) and beta cell function (HOMA β-cell) were calculated from fasting glucose and insulin levels. In male, the value of HOMA-IR and HOMA β-cell was the highest among 30's and decreased as the age increased. In female, the value of HOMA-IR increased with age, while HOMA β-cell decreased. High HOMA-IR and low HOMA β-cell were associated with the highest value of fasting glucose and systolic blood pressure. Low HOMA-IR and high HOMA β-cell showed the lowest concentration of fasting glucose and the highest concentration of HDL cholesterol. High HOMA-IR and high HOMA β-cell were connected with BMI, Total cholesterol, LDL cholesterol, and Triglycerides. There was a negative correlation between HOMA β-cell and age. The correlation coefficients of HOMA-IR and HOMA β-cell showed the highest value among weight, BMI and WC.
참고문헌 (32)
- Ascaso JF, "Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism", Diabetes Care, 26, pp.3320~3325 (2003)
- Bergman RN, "Quantitative estimation of insulin sensitivity", Am J Physiol, 236, pp.667~677 (1979)
- Bonora E, "Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study", Diabetes, 53, pp.1782~1789 (2004)
- Bonora E, "Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity", Diabetes Care, 23, pp.57~63 (2000)
- 최은숙, "한국인 남성에서 Homeostasis Model Assessment 표지자로 측정한 인슐린저항성 및 인슐린분비능과 당뇨병 발생위험도", Diabetes and Metabolism Journal, 32(6), pp.498~505 (2008), 대한당뇨병학회
- Dalla Man C, "Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals", Diabetes, 54, pp.3265~3273 (2005)
- DeFronzo RA, "Glucose clamp technique: A method for quantifying insulin secretion and resistance", Am J Physiol, 237, pp.214~223 (1979)
- Desprées JP, "Hyperinsulinemia as an independent risk factor for ischemic heart disease", N Engl J Med, 334, pp.952~957 (1996)
- Facchini FS, "Insulin resistance as a predictor of age-related diseases", J Clin Endocrinol Metab, 86, pp.3574~3578 (2001)
- Haffner SM, "A prospective analysis of the HOMA model", Diabetes Care, 19, pp.1138~1141 (1996)
- Harano Y, "Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo", Metabolism, 27, pp.1449~1452 (1978)
- Himsworth H., "Diabetes mellitus: a differentiation into insulin-sensitive and insulin-insensitive types", Lancet, 1, pp.127~130 (1936)
- Huh KB, "The Correlation between Insulin Resistance and the Pattern of Body Fat Distribution in Korean Patients with Non-insulin Dependent Diabetes Mellitus", Korean J Med, 44, pp.1~18 (1993)
- Jones CN, "Roles of insulin resistance and obesity in regulation of plasma insulin concentrations", Am J Physiol Endocrinol Metab, 278, pp.E501~E508 (2000)
- Kahn BB, "Obesity and insulin resistance", J Clin Invest, 106, pp.473~481 (2000)
- Kahn SE, "The relative contributions of insulin resistance and beta- cell dysfunction to the pathophy- siology of type 2 diabetes", Diabetologia, 46, pp.3~19 (2003)
- 김지현, "당뇨병이 없는 한국 성인에서 인슐린 저항성의 임상지표", 대한내과학회지, 73(6), pp.611~617 (2007), 대한내과학회
- Kwon HC, "Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults", Korean J Obes, (14), pp.69~75 (2005)
- Martin BC, "Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study", Lancet, 340, pp.925~929 (1992)
- Matthews DR, "Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man", Diabetologia, 28, pp.412~419 (1985)
- McAuley KA, "Diagnosing insulin resistance in the general population", Diabetes Care, 24, pp.460~464 (2001)
- McLaughlin T, "Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women", Metabolism, 50, pp.795~800 (2001)
- Mokdad AH, "The spread of the obesity epidemic in the United States, 1991-1998", JAMA, 282, pp.1519~1522 (1999)
- Muniyappa R, "Cardiovascular actions of insulin", Endocr Rev, 28, pp.463~491 (2007)
- Reaven GM, "The insulin resistance syndrome: definition and dietary approaches to treatment", Annu Rev Nutr, 25, pp.391~406 (2005)
- Ross R, "Reduction in obesity and related comorbid conditions after diet- induced weight loss or exercise-induced weight loss in men", Ann Intern Med, 133, pp.92~103 (2000)
- Shen SW, "Comparison of impedance to insulin- mediated glucose uptake in normal subjects and in subjects with latent diabetes", J Clin Invest, 49, pp.2151~2160 (1970)
- Song Y, "Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women", Diabetes Care, 30, pp.1747~1752 (2007)
- Strumvoll M, "Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity", Diabetes Care, 23, pp.295~301 (2000)
- Tripathy D, "Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons for the Botnia study", Diabetes, 49, pp.975~980 (2000)
- Yeni-Komshian H, "Relationship between several surrogate estimates of insulin resistance and quantification of insulinmediated glucose disposal in 490 healthy nondiabetic volunteers", Diabetes Care, 23, pp.171~175 (2000)
- Yip J, "Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease", J Clin Endocrinol Metab, 83, pp.2773~2776 (1998)